Pharmaceutical liposomes may serve as nanocarriers for sensitive drugs. They act as targeted controlled release formulations being administered by different routes. Advanced strategies in the development of liposome nanocarriers include polymer coating and surface functionalization with ligands or antibodies.
Our research group is interested in